3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV

被引:17
作者
Aly, Hussein Hassan [1 ]
Shimotohno, Kunitada [2 ]
Hijikata, Makoto [1 ,3 ]
机构
[1] Kyoto Univ, Dept Viral Oncol, Inst Virus, Lab Human Tumor Viruses,Sakyo Ku, Kyoto 6068507, Japan
[2] Keio Univ, Ctr Human Metab Syst Biol, Shinjuku Ku, Tokyo 1608582, Japan
[3] Kyoto Univ, Grad Sch Biostudies, Lab Viral Oncol, Sakyo Ku, Kyoto 6068501, Japan
关键词
Hepatitis C virus; Infection; Replication; 3D culture; PPAR; Immortalized hepatocytes; Blood-borne HCV; HEPATITIS-C-VIRUS; PROLIFERATOR-ACTIVATED-RECEPTOR; GENE-EXPRESSION; REPLICATION; INFECTION; RNA; CYCLOSPORINE; ENHANCEMENT; INHIBITION; LIVER;
D O I
10.1016/j.bbrc.2008.12.054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Due to the high polymorphism of natural hepatitis C virus (HCV) variants, existing recombinant HCV replication models have failed to be effective in developing effective anti-HCV agents. In the current study, we describe an in vitro system that Supports the infection and replication of natural HCV from patient blood using an immortalized primary human hepatocyte cell line cultured in a three-dimensional (3D) culture system. Comparison of the gene expression profile of cells cultured in the 3D system to those cultured in the existing 2D system demonstrated an up-regulation of several genes activated by peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling. Furthermore, using PPAR alpha agonists and antagonists, we also analyzed the effect of PPAR alpha signaling on the modulation of HCV replication using this system. The 3D in vitro system described in this study provides significant insight into the search for novel anti-HCV strategies that are specific to various strains of HCV. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:330 / 334
页数:5
相关论文
共 20 条
[1]   Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes [J].
Aly, Hussein H. ;
Watashi, Koichi ;
Hijikata, Makoto ;
Kaneko, Hiroyasu ;
Takada, Yasutugu ;
Egawa, Hiroto ;
Uemoto, Shinji ;
Shimotohno, Kunitada .
JOURNAL OF HEPATOLOGY, 2007, 46 (01) :26-36
[2]   Three-dimensional culture models for human viral diseases and antiviral drug development [J].
Andrei, Graciela .
ANTIVIRAL RESEARCH, 2006, 71 (2-3) :96-107
[3]   Efficient initiation of HCV RNA replication in cell culture [J].
Blight, KJ ;
Kolykhalov, AA ;
Rice, CM .
SCIENCE, 2000, 290 (5498) :1972-1974
[4]   Alcohol and lipid metabolism [J].
Crabb, David W. ;
Liangpunsakul, Suthat .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 :S56-S60
[5]   Mechanisms of N-acetylcysteine-driven enhancement of MK886-induced apoptosis [J].
Deshpande, V. S. ;
Kehrer, James P. .
CELL BIOLOGY AND TOXICOLOGY, 2006, 22 (04) :303-311
[6]  
Dickson R C, 1997, Clin Liver Dis, V1, P569, DOI 10.1016/S1089-3261(05)70322-6
[7]   In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin [J].
El-Farrash, Mohamed A. ;
Aly, Hussein H. ;
Watashi, Koichi ;
Hijikata, Makoto ;
Egawa, Hiroto ;
Shimotohno, Kunitada .
MICROBIOLOGY AND IMMUNOLOGY, 2007, 51 (01) :127-133
[8]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[9]   Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811 [J].
Goto, K ;
Watashi, K ;
Murata, T ;
Hishiki, T ;
Hijikata, M ;
Shimotohno, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (03) :879-884
[10]  
Heathcote EJ, 2007, J VIRAL HEPATITIS, V14, P82